| Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. | thyroid, |
| Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. | lymphoma, |
| miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. | retinoblastoma, |
| miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. | colorectal, |
| miR-106b-25/miR-17-92 clusters are polycistrons with oncogenic roles in hepatocellular carcinoma [review] | liver, |
| miR-92a promotes cervical cancer cell proliferation, cell cycle transition from G1 to S phase and invasion.FBXW7 counteracts the oncogenic effects of miR-92a on cervical cancer cells. | cervical, |
| Results showed that miR-92a expression was increased in osteosarcoma (OS) tissues, and its high expression was correlated with clinical stage, T classification and histological differentiation. MiR-92a seemed to exert an oncogenic role by targeting PTEN/AKT pathway in OS. | osteosarcoma, |
| Our results show that two known oncogenic miRs, miR-155 and -92a were upregulated and the tumour suppressor miR-150 was downregulated in the lymph node proliferation centres in chronic lymphocytic leukaemia/small lymphocytic lymphoma | lymphoma, |
| A microRNA polycistron as a potential human oncogene. | None |